Skip to main content

WPI 2356 Pill: white, capsule/oblong, 14mm

The pill with imprint WPI 2356 (White, Capsule/Oblong, 14mm) has been identified as Topiramate Extended-Release 25 mg and is used for Lennox-Gastaut Syndrome, Migraine Prevention, Epilepsy, Seizure Prevention, and Seizures. It belongs to the drug class carbonic anhydrase inhibitor anticonvulsants and is not a controlled substance.

Images for WPI 2356

Topiramate extended-release 25 mg WPI 2356

Topiramate Extended-Release

Imprint
WPI 2356
Strength
25 mg
Color
White
Size
14.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
00480-2356

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.